Widow maker

Preorders Open: Photo Book 'We Deserve This' Highlights Transgender Auto Enthusiasts

Retrieved on: 
Monday, February 26, 2024
Woman, Individual, Culture, Coffee, Sun, Widow maker, Car, Beauty, Book

LONG BEACH, Calif., Feb. 26, 2024 /PRNewswire/ -- Carrara Media proudly announces the preorder period for its latest release, a coffee table book called "We Deserve This," available now. The visually stunning book, photographed by renowned automotive journalist Victoria Scott, features captivating photo spreads of more than 20 transgender models paired with unique and fascinating automobiles.

Key Points: 
  • Preorders are open now for the coffee table book "We Deserve This," exclusively through CarraraBooks.com, with other major retailers to follow.
  • The visually stunning book, photographed by renowned automotive journalist Victoria Scott, features captivating photo spreads of more than 20 transgender models paired with unique and fascinating automobiles.
  • Coffee table book We Deserve This is a work that auto enthusiasts, fashionistas and trans women can all enjoy together.
  • Through Scott's lens, "We Deserve This" leads readers on a journey that highlights the beauty of individuality and a shared passion for automobiles.

Scripps La Jolla First in U.S. to Use ZOLL’s FDA-approved Supersaturated Oxygen Therapy on Patients Suffering From Widowmaker Heart Attacks

Retrieved on: 
Tuesday, January 14, 2020
Technology, Medical devices, Hospitals, FDA, Cardiology, Software, Other Health, Biotechnology, Health, Data management, Medicine, Cardiovascular system, Circulatory system, Aging-associated diseases, RTT, Medical emergencies, Angioplasty, Interventional radiology, Myocardial infarction, Widow maker, Transmyocardial revascularization, ZOLL Medical Corporation, Asahi Kasei

ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that Scripps Memorial Hospital La Jolla, in San Diego, Calif., treated its first widowmaker heart attack patient with SuperSaturated Oxygen (SSO2) Therapy.

Key Points: 
  • ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that Scripps Memorial Hospital La Jolla, in San Diego, Calif., treated its first widowmaker heart attack patient with SuperSaturated Oxygen (SSO2) Therapy.
  • For many patients, even after blood flow is quickly restored with angioplasty and stenting, irreversible damage to the heart muscle may occur.
  • SSO2 Therapy delivers localized superoxygenated blood, with the goal of improving microvascular blood flow and reducing damage to the heart muscle.
  • More than 30% percent of severe heart attack patients develop heart failure,3 and of those, 50% will die within five years.3 SSO2 Therapy has been shown in randomized prospective clinical trials to safely reduce infarct size in widowmaker heart attack patients.